Rafarma Pharmaceuticals (Laskavy Patent) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Rafarma Pharmaceuticals (Laskavy Patent) General Information


Portfolio of medicinal patent right in the United States. The asset offers the company access to several new technologies including the new generation immune modulator XR.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Primary Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rafarma Pharmaceuticals (Laskavy Patent) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rafarma Pharmaceuticals (Laskavy Patent)‘s full profile, request access.

Request a free trial